期刊文献+

血清降钙素原在急诊脓毒症早期诊断中的意义 被引量:16

Clinical value of procalcitonin test for early diagnosis of sepsis in the emergency department
暂未订购
导出
摘要 目的探讨降钙素原(PCT)对急诊脓毒症的早期诊断价值。方法 2010年10月—2011年4月将收住急诊抢救室的74例患者按诊断标准分为严重脓毒症(SS)组25例、脓毒症(sepsis)组25例、全身炎性反应综合征(SIRS)组11例、非全身炎性反应综合征(Non-S1RS)组13例,分别检测PCT、C反应蛋白(CRP)和白细胞(WBC)计数,并记录急性生理学和慢性健康状况评分Ⅱ(APACHEⅡ)。结果 SS组血清PCT、WBC、CRP水平及APACHEⅡ评分明显升高,其次为sepsis组,SIRS组和Non-SIRS组较低,各组间差异均有统计学意义(P<0.05)。以PCT≥0.5ng/ml为临界点,诊断脓毒症的敏感性为82.0%,特异性91.7%,均高于CRP、WBC计数。PCT的ROC曲线下面积大于CRP与WBC,血清PCT与CRP、APACHEⅡ评分呈明显正相关(r=0.724,r=0.475,P<0.01),CRP与APACHEⅡ评分呈正相关(r=0.389,P=0.001)。结论 PCT对急诊脓毒症具有较高的早期诊断价值。PCT与脓毒症患者的严重程度相关,是评估感染严重程度的较好参数。 Objective To investigate the diagnostic value of procalcitonin(PCT) as an early indicator for sepsis in emergency department.Methods From Oct 2010 to Apr 2011.according to the definition of sepsis defined by ACCP/SCCM Consensus Conference,74 emergency patients were divided into four groups:severe sepsis(SS) group(n = 25),sepsis group(n =25),SIRS group(n =11),non systemic inflammatory response syndrome(Non-SIRS) group(n = 13).The serum level of PCT,C reactive protein(CRP),white blood cell(WBC) count of each patient were measured,and the acute physiology and chronic health evaluation score II(APACHE II) were calculated.Results Serum level of PCT,WBC,CRP and APACHE II in the SS group was significantly elevated,followed by sepsis group,SIRS group and Non-SIRS group(P〈0.05 ).There were significant differences among the groups.Receiver operating characteristic curve(ROC curve) were drawn and areas under these curves were calculated.For the assessment of sepsis,at a cutoff level of PCT≥0.5 ng/ml,the sensitivity was 82.0%,the specificity was 91.7%,higher than the levels of CRP and WBC count.Serum level of PCT has a positive relationship with CRP,APACHEⅡscore(r = 0.724,r = 0.475,P〈0.01 ),CRP has positive relationship with APACHEⅡscore(r =0.389,P =0.001).Conclusion PCT was a prospective marker of bacterial infection,and substantially useful to early diagnosis of sepsis in the ED setting.PCT could be a better marker for assessing sepsis of critically ill patients.
出处 《疑难病杂志》 CAS 2013年第7期510-512,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 降钙素原 脓毒症 早期诊断 Procalcitonin Sepsis Early diagnosis
  • 相关文献

参考文献13

  • 1Riedel S, Melendez JH, An AT, et al. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department [J]. Am J Clin Pathol,2011,135(2) :182-189.
  • 2吴熙,于学忠.降钙素原[J].中国医学科学院学报,2008,30(2):231-235. 被引量:81
  • 3American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [J]. Crit Care Med, 1992,20(6) :864-874.
  • 4Ferrer R, Artigas A, Suarez D, et al. Effectiveness of treatment for severe sepsis [J]. Am J Respir Crit Care Med, 2009 ,180 ( 9) : 861 -866.
  • 5Jones AE, Fiechtl JF , Brown MD, et al. Procalcitonin test in the diagnosis of bacteremia: a Meta-analysis[J]. Ann Emerg Med,2007, 50( 1): 34-41.
  • 6Schuetz P, Albrich W, Christ-Crain M, et al. Pracalcitonin far guidance af antibiotic therapy[J]. Expert Rev Anti Infect Ther,20I0,8(5) :575- 587.
  • 7Hatzistilianou M. Diagnostic and prognostic role of procalcitanin in infectians[J]. Sci Warld J ,2010,10: 1941-1946.
  • 8Assicot M, Gendrel D, Carsin H, et al, High serum procalcitonin concentrations in patients with sepsis and infection [J]. Lancet, 1993 ,341 (8844) :515-518.
  • 9Endo S ,Aikawa N ,Fujishima S,et al. Usefulness of procalcitonin serum level far the discrimination of severe sepsis from sepsis: a multicenter prospective study[J]. J Infect Chemother,2008,14(3) :244-249.
  • 10Nobre V, Harbarth S, Graf JD. Use of procalcitonin to shorten antibiotic treatment duration in septic patients [J]. Am J Respir Crit Care Med, 2008,177 (5) :498-505.

二级参考文献33

  • 1胡如雪.降钙素原(PCT)的临床应用价值[J].江西医学检验,2005,23(3):259-259. 被引量:41
  • 2Wenzel RP. Anti-endotoxin monoclonal antibodies: a second look [J]. N Engl J Med, 1992, 326(17) :1151-1153.
  • 3Russwurm S, Wiederhold M, Oberhoffer M. Molecular aspects and natural source of procalcitonin [ J ]. Clin Chem Lab Med, 1999, 37(8) :789-797.
  • 4Bohuon C. A brief history of procalcitonin [ J ]. Intensie Care Med, 2000, 26(Suppl 4) :S146-S147.
  • 5Fisher LA, Kikkawa DO, Rivier JE, et al. Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide [J]. Nature, 1983, 305(5934) :534-536.
  • 6Strider RH Jr, Nylen ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization [J]. J Investig Med, 1997, 45 (9) :552-560.
  • 7Russwurm S, Wiederhold W, Oberhoffer M, et al. Procalcitonin as monocytic marker for early diagnosis in septic abortion [J]. Z Geburtsh Neonatol, 2000, 204(1) :34-38.
  • 8Oberhoffer M, Vogelsang H, Jauger E, et al. Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content [J]. J Crit Care, 1999, 14(1) :29-33.
  • 9Meisner M, Tschaikowsky K, Schnabel S, et al. Procalcitonin influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations [ J ]. Eur J Clin Chem Clin Biochem, 1997, 35(8):597-601.
  • 10Oberhoffer M, Stonauns I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro [J]. J Lab Clin Med, 1999, 134(1) :49- 55.

共引文献80

同被引文献185

  • 1洪军,陈敏华.临床肺部感染评分评估呼吸机相关性肺炎预后的研究[J].中国呼吸与危重监护杂志,2011,10(3):289-291. 被引量:32
  • 2王伟,孙雨梅,吕德辉,刘树清.肝病性全血细胞减少56例分析[J].现代医药卫生,2006,22(14):2178-2179. 被引量:1
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8243
  • 4Sethi S. Pathogenesis and treatment of acute exacerbations of chronic ob- structive pulmonary disease[ J]. Semin Respir Crit Care Med,2005, 26 (2) : 192-203.
  • 5Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic anflam- marion, infection and sepsis : clinical utility and limitations [ J ]. Cfit Care Med,2008,36(2) : 941-952.
  • 6Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy[ J]. Expert Rev Anti Infect Ther,2010,8 (5) :575- 587.
  • 7Esper AM, Martin GS. Extending international sepsis epidemiology : the impact of organ dysfunction [ J ]. Critical Care ,2009,13 ( 1 ) : 1-3.
  • 8Mayr FB, Yende S,Angus DC. Epidemiology of severe sepsis [ J ]. Viru- lence,2014,5( 1 ) :4-11.
  • 9Sugitharini V, Prema A, Beda-Thangam E. Inflammatory mediators of systemic inflammation in neonatal sepsis [ J. Inflamm Res, 2013,62 ( 12 ) : 1025-1034.
  • 10Jiang LN, Yao YM, Sheng ZY. The role of regulatory T cells in the path- ogenesis of sepsis and its clinical implication [ J ]. J Interferon Cytokine Res,2012,32(8) :341-349.

引证文献16

二级引证文献178

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部